+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Recombinant Proteins Market - Global Forecast 2026-2032- Product Image
Recombinant Proteins Market - Global Forecast 2026-2032- Product Image
New

Recombinant Proteins Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5592125
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers navigating the recombinant proteins market face a rapidly evolving landscape shaped by ongoing technological advances, supply chain recalibration, and expanding clinical and research applications. This analysis provides essential intelligence for formulating growth strategies, managing operational risks, and capitalizing on emerging opportunities within the sector.

Market Snapshot: Recombinant Proteins Market Growth and Outlook

The Recombinant Proteins Market grew from USD 6.65 billion in 2025 to USD 7.62 billion in 2026. It is expected to continue growing at a CAGR of 14.89%, reaching USD 17.57 billion by 2032. This trajectory reflects strong demand across diagnostics, research, therapeutic development, and vaccines. Strategic alignment with evolving manufacturing capabilities, regulatory frameworks, and partnership models positions stakeholders to capture value as the competitive landscape shifts.

Scope & Segmentation

  • Application Areas: Diagnostics (including imaging agents and in vitro diagnostics), research and development (encompassing drug discovery and process development), therapeutics (notably autoimmune, oncology, and cardiovascular disease focus), and vaccines (prophylactic and therapeutic approaches).
  • Product Types: Cytokines, enzymes, growth factors, and hormones, with selection tailored by functional attributes and validation needs.
  • Expression Systems: Bacterial (e.g., E. coli), insect (baculovirus systems), mammalian (CHO, HEK), plant-based, and yeast hosts; each with unique production and regulatory considerations.
  • End User Profiles: Academic and research institutes, contract research organizations, diagnostic laboratories, and pharmaceutical or biotech companies, ranging from large pharma to small and medium firms.
  • Product Forms: Both liquid and lyophilized (freeze-dried) products, affecting stability and logistics requirements.
  • Sales Channels: Direct sales and distributor partnerships shape customer engagement and margin structures.
  • Regions: Detailed analysis covers the Americas, Europe, Middle East & Africa, and Asia-Pacific, highlighting investment drivers, talent concentration, and regulatory approaches that influence market dynamics.

Key Takeaways: Strategic Insights for Senior Executives

  • Technological maturation in molecular biology and expression platforms is accelerating innovation cycles and enabling access to a wider spectrum of recombinant biologics.
  • Emerging manufacturing models, including modular production and contract development and manufacturing organization partnerships, lower entry barriers for smaller innovators while supporting scale-ups for established players.
  • Quality assurance, regulatory readiness, and traceability remain paramount, especially as product portfolios expand from research reagents to therapeutic and diagnostic applications.
  • Strategic investments in flexible manufacturing and robust analytics can maximize operational resilience, a critical advantage in navigating supply chain challenges and policy shifts.
  • Segmentation analysis reveals that successful suppliers align technology, documentation, and service models closely with end-user requirements.
  • Regional variations in manufacturing capacity, talent availability, and regulatory environment shape market entry strategies, technology adoption rates, and partnership models.

Tariff Impact on Supply Chain and Sourcing Strategies

Recent tariff adjustments in the United States are prompting organizations to reevaluate sourcing and manufacturing strategies for recombinant proteins and related raw materials. Increased customs duties on laboratory consumables and bioprocess inputs are driving changes in supplier portfolios and, at times, relocation of manufacturing closer to end markets. Companies are responding by diversifying suppliers, adopting strategic sourcing, increasing regional contract manufacturing, and enhancing supply chain transparency. Tariff-driven complexity accentuates the value of vertically integrated operations, flexible manufacturing, and multi-sourcing to ensure operational resilience.

Methodology & Data Sources

This report combines expert interviews with comprehensive literature review and analysis of public regulatory documents. Systematic cross-validation with procurement and manufacturing case studies grounds insights in operational realities. Methodology emphasizes transparency of assumptions and robust evidence triangulation to inform strategic choices for industry leaders.

Why This Report Matters

  • Gain a clear, segmentation-driven view of evolving market opportunities and operational challenges in the recombinant proteins sector.
  • Understand the impact of technological, regional, and policy trends on competitive positioning and strategic planning.
  • Leverage actionable insights for aligning product development, manufacturing, and go-to-market initiatives with growth priorities and compliance frameworks.

Conclusion

A data-driven approach to the recombinant proteins market empowers organizations to anticipate trends, optimize operations, and sustain strategic advantage. Proactive adaptation to technological innovation and policy shifts will drive market leadership and unlock long-term value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Recombinant Proteins Market, by Product Type
8.1. Cytokines
8.2. Enzymes
8.3. Growth Factors
8.4. Hormones
9. Recombinant Proteins Market, by Expression System
9.1. Bacterial
9.2. Insect
9.3. Mammalian
9.3.1. CHO Cells
9.3.2. HEK Cells
9.4. Plant
9.5. Yeast
9.5.1. Pichia Pastoris
9.5.2. Saccharomyces Cerevisiae
10. Recombinant Proteins Market, by Form
10.1. Liquid Form
10.2. Lyophilized Form
11. Recombinant Proteins Market, by Sales Channel
11.1. Direct Sales
11.2. Distribution Partners
12. Recombinant Proteins Market, by Application
12.1. Diagnostics
12.1.1. Imaging Agents
12.1.2. In Vitro Diagnostics
12.2. Research And Development
12.2.1. Basic Research
12.2.2. Drug Discovery
12.2.3. Process Development
12.3. Therapeutics
12.3.1. Autoimmune
12.3.2. Cardiovascular
12.3.3. Oncology
12.4. Vaccines
12.4.1. Prophylactic
12.4.2. Therapeutic
13. Recombinant Proteins Market, by End User
13.1. Academic And Research Institutes
13.2. Contract Research Organizations
13.3. Diagnostic Laboratories
13.4. Pharmaceutical And Biotech Companies
13.4.1. Large Pharma
13.4.2. Small And Medium Biotech
14. Recombinant Proteins Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Recombinant Proteins Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Recombinant Proteins Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Recombinant Proteins Market
18. China Recombinant Proteins Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abcam plc
19.6. Bio-Rad Laboratories, Inc.
19.7. Bio-Techne Corporation
19.8. Boehringer Ingelheim International GmbH
19.9. Danaher Corporation
19.10. Eli Lilly and Company
19.11. F. Hoffmann-La Roche Ltd.
19.12. Lonza Group Ltd.
19.13. Merck KGaA
19.14. Novo Nordisk A/S
19.15. Sanofi S.A
19.16. Sartorius AG
19.17. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL RECOMBINANT PROTEINS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL RECOMBINANT PROTEINS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA RECOMBINANT PROTEINS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CYTOKINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CYTOKINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CYTOKINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY GROWTH FACTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY GROWTH FACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY HORMONES, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY HORMONES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY HORMONES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY INSECT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CHO CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CHO CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY HEK CELLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY HEK CELLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY HEK CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PLANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PICHIA PASTORIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PICHIA PASTORIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PICHIA PASTORIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SACCHAROMYCES CEREVISIAE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SACCHAROMYCES CEREVISIAE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SACCHAROMYCES CEREVISIAE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY LIQUID FORM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY LIQUID FORM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY LYOPHILIZED FORM, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY LYOPHILIZED FORM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY LYOPHILIZED FORM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DISTRIBUTION PARTNERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DISTRIBUTION PARTNERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DISTRIBUTION PARTNERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY IMAGING AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY IMAGING AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY IMAGING AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY BASIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY BASIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PROCESS DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PROCESS DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY AUTOIMMUNE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY AUTOIMMUNE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PROPHYLACTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PROPHYLACTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PROPHYLACTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY LARGE PHARMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY LARGE PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SMALL AND MEDIUM BIOTECH, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SMALL AND MEDIUM BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY SMALL AND MEDIUM BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2032 (USD MILLION)
TABLE 183. EUROPE RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. EUROPE RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 185. EUROPE RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
TABLE 186. EUROPE RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 187. EUROPE RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 188. EUROPE RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 189. EUROPE RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 190. EUROPE RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 191. EUROPE RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 192. EUROPE RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 193. EUROPE RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 194. EUROPE RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 195. EUROPE RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. EUROPE RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2032 (USD MILLION)
TABLE 211. AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 212. AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 213. AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
TABLE 214. AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 215. AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 216. AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 217. AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 218. AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 219. AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 220. AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 221. AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 222. AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 223. AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2032 (USD MILLION)
TABLE 239. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 240. ASEAN RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. ASEAN RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 242. ASEAN RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
TABLE 243. ASEAN RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 244. ASEAN RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 245. ASEAN RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 246. ASEAN RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 247. ASEAN RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 248. ASEAN RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 249. ASEAN RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 250. ASEAN RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 251. ASEAN RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 252. ASEAN RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 253. ASEAN RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2032 (USD MILLION)
TABLE 254. GCC RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 255. GCC RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 256. GCC RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
TABLE 257. GCC RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 258. GCC RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 259. GCC RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 260. GCC RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 261. GCC RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 262. GCC RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 263. GCC RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 264. GCC RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 265. GCC RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 266. GCC RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. GCC RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2032 (USD MILLION)
TABLE 282. BRICS RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 283. BRICS RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 284. BRICS RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
TABLE 285. BRICS RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 286. BRICS RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 287. BRICS RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 288. BRICS RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 289. BRICS RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 290. BRICS RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 291. BRICS RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 292. BRICS RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 293. BRICS RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 294. BRICS RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 295. BRICS RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2032 (USD MILLION)
TABLE 296. G7 RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 297. G7 RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 298. G7 RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
TABLE 299. G7 RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 300. G7 RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 301. G7 RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 302. G7 RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 303. G7 RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 304. G7 RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 305. G7 RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 306. G7 RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 307. G7 RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 308. G7 RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 309. G7 RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2032 (USD MILLION)
TABLE 310. NATO RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 311. NATO RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 312. NATO RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
TABLE 313. NATO RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 314. NATO RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 315. NATO RECOMBINANT PROTEINS MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 316. NATO RECOMBINANT PROTEINS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
TABLE 317. NATO RECOMBINANT PROTEINS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 318. NATO RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 319. NATO RECOMBINANT PROTEINS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 320. NATO RECOMBINANT PROTEINS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 321. NATO RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 322. NATO RECOMBINANT PROTEINS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 323. NATO RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2032 (USD MILLION)
TABLE 324. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 325. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 326. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 327. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
TABLE 328. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY MAMMALIAN, 2018-2032 (USD MILLION)
TABLE 329. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY YEAST, 2018-2032 (USD MILLION)
TABLE 3

Companies Mentioned

The key companies profiled in this Recombinant Proteins market report include:
  • Abcam plc
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Boehringer Ingelheim International GmbH
  • Danaher Corporation
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Lonza Group Ltd.
  • Merck KGaA
  • Novo Nordisk A/S
  • Sanofi S.A
  • Sartorius AG
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.62 Billion
Forecasted Market Value ( USD ) by 2032 $ 17.57 Billion
Compound Annual Growth Rate14.8%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Human Procalcitonin Recombinant Protein Market - Global Forecast 2025-2030 - Product Image

Human Procalcitonin Recombinant Protein Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Human Leukemia Inhibitory Factor Recombinant Protein Market - Global Forecast 2025-2030 - Product Image

Human Leukemia Inhibitory Factor Recombinant Protein Market - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Custom Recombinant Proteins Market - Global Strategic Business Report - Product Image

Custom Recombinant Proteins Market - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Recombinant Proteins Market - Global Strategic Business Report - Product Image

Recombinant Proteins Market - Global Strategic Business Report

  • Report
  • 214 Pages
  • Global
From
Recombinant Proteins Manufacturing Services Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030 - Product Image

Recombinant Proteins Manufacturing Services Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.